首页> 外文OA文献 >Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register

【2h】

Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register

机译：Rituctory Systemic狼疮性红斑狼疮性红斑狼疮的短期疗效和安全性：英国群岛Lupus评估组生物学登记的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Eoghan M McCarthy; Emily Sutton; Stephanie Nesbit; James White; Ben Parker; David Jayne; Bridget Griffiths; David A Isenberg; Anisur Rahman; Caroline Gordon; David P DCruz; Benjamin Rhodes; Peter Lanyon; Edward M Vital; Chee-Seng Yee; Christopher J Edwards; Lee-Suan Teh; Mohammed Akil; Neil J McHugh; Asad Zoma; Ian N Bruce;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy [J] . Tanaka Yoshiya, Takeuchi Tsutomu, Miyasaka Nobuyuki, Modern rheumatology . 2016,第1期

机译：利妥昔单抗在日本系统性红斑狼疮和狼疮肾炎患者中的常规治疗无效
2. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial† [J] . Joan T. Merrill, C. Michael Neuwelt, Daniel J. Wallace, Arthritis & Rheumatism . 2010,第1期

机译：利妥昔单抗在中度至重度活动性系统性红斑狼疮中的疗效和安全性：利妥昔单抗试验的随机，双盲，ii / iii期系统性红斑狼疮评估†
3. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial [J] . MerrillJ.T., NeuweltC.M., WallaceD.J., Arthritis and Rheumatism . 2010,第1期

机译：利妥昔单抗在中度至重度活动性系统性红斑狼疮中的疗效和安全性：利妥昔单抗试验的随机，双盲，II / III期系统性红斑狼疮评估
4. Serum Levels of Leptin in Patients with Systemic Lupus Erythematosus: Correlated with Lupus Activity [C] . XU Ting, JIN Ou-yang, ZHAO Sheng-nan, International Forum on Progress on Post-Genome Technologies(5'IFPT); 20070910-11; Suzhou(CN) . 2007

机译：系统性红斑狼疮患者血清瘦素水平：与狼疮活动相关
5. Investigating B cell and T cell Cognate Interactions in Systemic Lupus Erythematosus: A Novel System for the Study of Lupus Antigen-Specific T cells. [D] . Giles, Josephine Ruth. 2015

机译：研究系统性红斑狼疮中B细胞和T细胞同源相互作用：研究狼疮抗原特异性T细胞的新型系统。
6. Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register [O] . Eoghan M McCarthy, Emily Sutton, Stephanie Nesbit, -1

机译：利妥昔单抗治疗难治性系统性红斑狼疮的近期疗效和安全性：不列颠群岛狼疮评估小组生物制剂注册结果
7. 300 Predictors of early response to rituximab in systemic lupus erythematosus (sle): results from the british isles lupus assessment group biologics register (bilag-br) [O] . S Nesbit, E Sutton, E McCarthy, 2017

机译：300次早期反应的预测因素狼疮狼疮（SLE）：英国群岛卢布评估组生物制剂（BILAG-BR）的结果

Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register

著录项

引文网络

相似文献

相关主题

期刊订阅